Rocket Lab, Trade Desk, Hims Price Targets, November 10 2026

Rocket Lab

Rocket Lab launches small satellites on its Electron rocket and builds spacecraft and satellite parts for government and commercial customers. It is developing a larger rocket called Neutron. The company is based in Long Beach, California. It reported third-quarter results after the close on Monday. Revenue came to $268 million, 4.2% above the $257.17 million consensus. It lost $0.12 a share, against the $0.07 loss expected, a 71.4% wider loss.

What Drove Rocket Lab’s Quarter

Revenue grew 73% from a year earlier. Product revenue came to $197.5 million, up from $104.0 million. Service revenue grew to $70.3 million from $51.0 million. The gross margin was 33.6%, or 38.4% on an adjusted basis.

The net loss widened to $79.7 million from $18.3 million. However, the adjusted EBITDA loss narrowed to $18.0 million from $26.3 million. Backlog reached about $3.6 billion, 52% more than at the end of June. Rocket Lab now targets the first Neutron launch no earlier than 2027, with 16 Neutron missions already booked.

For the fourth quarter, Rocket Lab guides to revenue of $270 million to $290 million. The midpoint is 5.5% above the $265.5 million consensus. It sees an adjusted gross margin of 39% to 41%.

Six Desks Weigh In on Rocket Lab

Andres Sheppard of Cantor Fitzgerald kept Overweight and lowered his target from $122 to $111 today, a Tuesday. Anthony Valentini of Barclays kept Overweight and lowered his target from $85 to $82. John Godyn of Citi reiterated Buy with a $105 price target. Andre Madrid of BTIG reiterated Neutral. Alexander Potter of Piper Sandler kept Neutral and lowered his target from $83 to $58. Michael Leshock of KeyBanc reiterated Overweight with a $100 price target.

Rocket Lab’s Record on AnaChart

Rocket Lab draws 13 covering analysts on AnaChart. Their average target is $104.29, with a high of $135 and a low of $55. Ratings split 85% Buy and 15% Hold. AnaChart’s tracking shows 80.18% of Rocket Lab targets get met, after about 223 days on average.

Trade Desk

The Trade Desk runs a self-service platform that ad agencies and brands use to buy digital ads across connected TV, audio, mobile and the web. The company is based in Ventura, California. It reported third-quarter results after the close on Monday. Revenue came to $736 million, 13.1% above the $650.89 million consensus. Adjusted earnings were $0.33 a share, 32.0% above the $0.25 expected.

What Drove The Trade Desk’s Quarter

Revenue was 0.4% lower than a year earlier, when it came to $739 million. Net income shrank to $38 million from $116 million. That includes $44 million of restructuring charges. Adjusted EBITDA came to $266 million, a 36% margin, against 43% a year earlier. Customer retention stayed above 95%.

The board added $731 million to the buyback, for $1 billion in all. Netflix expanded its integration with the platform, letting advertisers target audiences with their own and outside data from November. For the fourth quarter, The Trade Desk guides to revenue of at least $755 million and adjusted EBITDA of at least $280 million. Chief executive Jeff Green said the company is “still operating below the level of growth we expect from ourselves.”

Eleven Desks Weigh In on The Trade Desk

Stephen Ju of UBS kept Buy and raised his target from $15 to $19 today. Shyam Patil of Susquehanna kept Neutral and raised his target from $14 to $17. Youssef Squali of Truist kept Hold and raised his target from $16 to $17. James Heaney of Jefferies raised his target from $12 to $14. Justin Patterson of KeyBanc reiterated Sector Weight.

Mark Mahaney of Evercore ISI kept In-Line and raised his target from $14 to $18. Matthew Swanson of RBC Capital kept Sector Perform and raised his target from $15 to $18. Michael Morris of Guggenheim kept Neutral and raised his target from $13 to $16. Matthew Cost of Morgan Stanley kept Equal Weight and raised his target from $13 to $14. Ronald Josey of Citi kept Sell and raised his target from $11 to $12. Alicia Reese of Wedbush reiterated Neutral with a $15 price target.

Patil sees a strong third quarter, a fourth-quarter outlook above expectations and longer-term growth drivers.

The Trade Desk’s Record on AnaChart

The Trade Desk draws 33 covering analysts on AnaChart. Their average target is $27.69, with a high of $70 and a low of $10. Ratings split 59.81% Buy, 30.84% Hold and 9.35% Sell. AnaChart’s tracking shows 68.32% of Trade Desk targets get met, after about 108 days on average.

Hims & Hers

Hims & Hers Health runs a telehealth platform that sells subscriptions for prescription treatments in weight loss, hair loss, sexual health and mental health. The company is based in San Francisco. It reported third-quarter results after the close on Monday. Revenue came to $890.4 million, 0.3% below the $892.88 million consensus. It lost $0.14 a share, against the $0.06 profit expected, a 333.3% shortfall.

What Drove Hims & Hers’ Quarter

Revenue grew 49% from a year earlier. U.S. revenue grew 21% to $657.1 million. Revenue outside the U.S. grew 321% to $233.3 million. Subscribers grew 13% to 2.79 million. Monthly revenue per average subscriber grew 30% to $105.

The gross margin was 57%, against 74% a year earlier. Hims & Hers posted a net loss of $33.0 million, after net income of $15.8 million a year earlier. Adjusted EBITDA came to $82.4 million, a 9% margin, down from 13%. Management said it held back marketing spend ahead of planned platform expansions in the fourth quarter.

For the fourth quarter, Hims & Hers guides to revenue of $875 million to $895 million. The midpoint is 7.3% below the $955.1 million consensus. For the full year it sees revenue of $3.13 billion to $3.15 billion, 2.2% below the $3.21 billion consensus at the midpoint.

Seven Desks Weigh In on Hims & Hers

Bryan Smilek of JPMorgan kept Neutral and lowered his target from $32 to $24 today. Ryan MacDonald of Needham kept Buy and lowered his target from $42 to $32. Jailendra Singh of Truist reiterated Hold with a $32 price target. Maria Ripps of Canaccord reiterated Buy with a $40 price target. Glen Santangelo of Barclays reiterated Buy with a $35 price target. Craig Hettenbach of Morgan Stanley kept Equal Weight and lowered his target from $28 to $25. Mahaney of Evercore ISI kept In-Line and raised his target from $24 to $27.

Singh tied a drop in subscribers from the second quarter to lower marketing. Ripps sees a better setup into the first quarter as weight-loss offerings and international markets expand.

Hims & Hers’ Record on AnaChart

Hims & Hers draws 13 covering analysts on AnaChart. Their average target is $29.21, with a high of $42 and a low of $21. Ratings split 57.5% Hold, 28.75% Buy and 13.75% Sell. AnaChart’s tracking shows 88.55% of Hims & Hers targets get met, after about 120 days on average.

What the Performance Matrix Shows

Hims & Hers has the best met ratio of the three, and The Trade Desk the lowest. A Trade Desk target that gets met lands in about 108 days, against about 223 for Rocket Lab. AnaChart’s first Trade Desk forecast dates to September 2016, its first Hims & Hers forecast to February 2021 and its first Rocket Lab forecast to September 2021.

AnaChart tracks every price target against what happened to the stock afterward, desk by desk and analyst by analyst. The ticker pages linked above break out each record by analyst, firm and year. AnaChart’s full data set holds more than 760,000 analyst calls on more than 9,000 tickers, active and delisted. More than 680,000 carry a price target and more than 730,000 carry a rating. It is the second largest database of its kind. The raw file is available through the AnaChart store.

The previous update covered DraftKings, Zillow and Molson Coors on November 9.

Top analyst price target moves on AnaChart, November 10 2026
Top analyst price target moves on AnaChart.com, November 10 2026